SHSE:603716 (China)
Â
Ordinary Shares - Class A
Â¥
15.89
+0.52 (+3.38%)
Jul 31
Business Description
Thalys Medical Technology Group Corp
ISIN : CNE1000030C3
Share Class Description:
SHSE:603716: Ordinary Shares - Class ATotal Employee Number:
1,045Compare
Compare
Traded in other countries / regions
603716.China Index Membership
SSE Composite Index IPO Date
2016-10-31Description
Thalys Medical Technology Group Corp is engaged in intensive sales business, pure sales, and research and development, production and sales of independent in vitro diagnostic products.
Financial Strength
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 0.37 | |||||
Equity-to-Asset | 0.59 | |||||
Debt-to-Equity | 0.37 | |||||
Debt-to-EBITDA | -2.75 | |||||
Piotroski F-Score | 3/9 | |||||
Altman Z-Score | 2.9 | |||||
Beneish M-Score | -3.23 | |||||
WACC vs ROIC | ||||||
Growth Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -23.1 | |||||
3-Year EBITDA Growth Rate | -104.3 | |||||
3-Year EPS without NRI Growth Rate | -7.3 | |||||
3-Year FCF Growth Rate | -17 | |||||
3-Year Book Growth Rate | -13.3 |
Momentum Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 59.87 | |||||
9-Day RSI | 56.55 | |||||
14-Day RSI | 53.63 | |||||
3-1 Month Momentum % | -34.62 | |||||
6-1 Month Momentum % | -37.16 | |||||
12-1 Month Momentum % | -53.7 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 1.61 | |||||
Quick Ratio | 1.33 | |||||
Cash Ratio | 0.19 | |||||
Days Inventory | 112.8 | |||||
Days Sales Outstanding | 302.61 | |||||
Days Payable | 135.46 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -1.1 | |||||
Shareholder Yield % | 14.33 |
Profitability Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 22.47 | |||||
Operating Margin % | -6.09 | |||||
Net Margin % | -21.67 | |||||
EBITDA Margin % | -14.1 | |||||
FCF Margin % | -0.69 | |||||
OCF Margin % | -0.16 | |||||
ROE % | -21.66 | |||||
ROA % | -10.42 | |||||
ROIC % | -4.03 | |||||
3-Year ROIIC % | 9.67 | |||||
ROC (Joel Greenblatt) % | -16.97 | |||||
ROCE % | -11.72 | |||||
Years of Profitability over Past 10-Year | 5 |
GF Value Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PS Ratio | 3.27 | |||||
PB Ratio | 3.37 | |||||
Price-to-Tangible-Book | 3.53 | |||||
EV-to-EBIT | -28.38 | |||||
EV-to-EBITDA | -28.38 | |||||
EV-to-Revenue | 4 | |||||
EV-to-FCF | -583.98 | |||||
Price-to-GF-Value | 3.38 | |||||
Price-to-Projected-FCF | 7.53 | |||||
| Price-to-Net-Current-Asset-Value | 7.64 | |||||
Earnings Yield (Greenblatt) % | -3.52 | |||||
FCF Yield % | -0.19 | |||||
Forward Rate of Return (Yacktman) % | -22.49 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Thalys Medical Technology Group Corp Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil ¥) | 971.321 | ||
| EPS (TTM) (Â¥) | -1.05 | ||
| Beta | 1.3551 | ||
| 3-Year Sharpe Ratio | 0.4 | ||
| 3-Year Sortino Ratio | 0.92 | ||
| Volatility % | 46.81 | ||
| 14-Day RSI | 53.63 | ||
| 14-Day ATR (Â¥) | 1.292226 | ||
| 20-Day SMA (Â¥) | 14.707 | ||
| 12-1 Month Momentum % | -53.7 | ||
| 52-Week Range (Â¥) | 12.92 - 38.12 | ||
| Shares Outstanding (Mil) | 225.79 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 3 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Thalys Medical Technology Group Corp Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Thalys Medical Technology Group Corp Stock Events
| Event | Date | Price (Â¥) | ||
|---|---|---|---|---|
| 2.5:1 Stock Split | 2018-04-25 | 26.92 (+8.64%) | ||
| 1.4:1 Stock Split | 2017-10-23 | 23.06 (-0.48%) |
Show
Entries
Thalys Medical Technology Group Corp Frequently Asked Questions
What is Thalys Medical Technology Group Corp(SHSE:603716)'s stock price today?
The current price of SHSE:603716 is ¥15.89. The 52 week high of SHSE:603716 is ¥38.12 and 52 week low is ¥12.92.
When is next earnings date of Thalys Medical Technology Group Corp(SHSE:603716)?
The next earnings date of Thalys Medical Technology Group Corp(SHSE:603716) is .
Does Thalys Medical Technology Group Corp(SHSE:603716) pay dividends? If so, how much?
Thalys Medical Technology Group Corp(SHSE:603716) does not pay dividend.
Press Release
| Subject | Date | ||
|---|---|---|---|
| China's Thalys and iCan: Israel-Cannabis Sign MOU for Co-investment in Cannabis and Hemp Related Startups | 2019-04-11 |
Articles on Thalys Medical Technology Group Corp
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers